Drug | Metabolism | Side effects | References | |
---|---|---|---|---|
In the mother | In the fetus | |||
Corticosteroids | IL-2 synthesis inhibition | Hypertension Gestational diabetes Osteonecrosis Cataracts Striae | Malformation (4%, esp. cleft palate) Low birth weight PROM Adrenal suppression Infection | |
Cyclosporine | Inhibition of cytokine production | Hypertension Gestational diabetes Renal dysfunction Uterine dystonia Seizures | Malformation (3–5%; no consistent pattern known) Low birth weight Jaundice Cytopenia Hypoglycemia Intracerebral hemorrhage | |
Azathioprine | Antimetabolic: inhibition of the biosynthesis of purine nucleotides | Leukopenia Gastrointestinal side effects | Malformation (7%; esp. aphallia, hypo- or dysplasia of lungs and urinary bladder) IUGR Premature delivery Adrenal hypoplasia Infection | |
Tacrolimus | Inhibition of T-lymphocytes activation by inhibition of calcineurin | Hypertension Gestational diabetes Renal dysfunction Neurotoxicity Diarrhea Alopecia Pruritus | Malformation (6%; no consistent pattern known) Transient increase of potassium Impaired renal function | |
Mycophenolate mofetil | Inhibition of de novo synthesis of purines | Leukopenia Gastrointestinal side effects | Malformation (22%; esp. cleft lip and palate, micrognathia, ear malformations) 1st trimester fetal loss Anemia |